Logo

Vox Markets

How the latest in vivo trial results strengthens and facilitates the extension of patent applications for POLB 001 in cancer immunotherapy-induced CRS

How the latest in vivo trial results strengthens and facilitates the extension of patent applications for POLB 001 in cancer immunotherapy-induced CRS

0 views
2 years ago
Author: Vox Markets

Money
Stocks
Investing
AIM
Stock Market
Shares
Equities
Poolbeg
Stocks to Follow
POLB
POLB 001
Main Market
immunotherapy
Powered bySeeen logo